Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
THERAPEUTIC COMPOSITIONS COMPRISING RILPIVIRIN HCL AND TENOVOFIR DISOPROXIL FUMARATE

No-Receipt date 2022-00722 - 25/02/2022
No-Filing date 20220400449 - 25/02/2022
No-Granting date 3084951.B2 - 11/03/2022
No-EPO application date 11791161.0 - 18/11/2011
No-EPO granting date 2640362 - 01/12/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2022 - 18/04/2022
Expiration date 19/11/2031
Kind of title Amended European Patent Validation
Legal status VALID
Priorities US415600 P19/11/2010/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/505
A61K 31/513
A61K 31/675
A61K 9/20
A61P 31/18

Related Documents

Related Titles
TypeMaster titleRelated title
[ADD] 20140402516

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1387013 GILEAD SCIENCES, INC. 333 LAKESIDE DRIVEFOSTER CITY, CA 94404 UNITED STATES OF AMERICA (USA)
1387014 JANSSEN SCIENCES IRELAND UC EASTGATE VILLAGE, EASTGATELITTLE ISLAND, COUNTY CORK IRELAND

Inventors
CodeFirstnameSurname
3569517 OLIYAI, REZA
3569518 WISER, LAUREN
3569519 MENNING, MARK

Representatives
CodeFirstnameSurnameAddressTownZip
3712ANTHOULAGALANOPOULOUTHESI LYSI MPITAKOUKAPANDRITI (ATTIKIS)19014

Contact
CodeFirstnameSurnameAddressTownZipCountry
9219ALKISTIS-EIRINIMALAMIVISSARIONOS 3ATHINA (ATTIKIS)10672 GREECE

Owners History

Title Instruments

Payments history 14 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015